0001567619-18-001854.txt : 20180828
0001567619-18-001854.hdr.sgml : 20180828
20180828180454
ACCESSION NUMBER: 0001567619-18-001854
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20180824
FILED AS OF DATE: 20180828
DATE AS OF CHANGE: 20180828
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Vazquez Adrian
CENTRAL INDEX KEY: 0001438326
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37392
FILM NUMBER: 181042593
MAIL ADDRESS:
STREET 1: 1010 N. CENTRAL AVENUE
STREET 2: SUITE 201
CITY: GLENDALE
STATE: CA
ZIP: 91202
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Apollo Medical Holdings, Inc.
CENTRAL INDEX KEY: 0001083446
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MANAGEMENT CONSULTING SERVICES [8742]
IRS NUMBER: 870042699
STATE OF INCORPORATION: DE
FISCAL YEAR END: 0331
BUSINESS ADDRESS:
STREET 1: 700 NORTH BRAND BLVD.,
STREET 2: SUITE 1400
CITY: GLENDALE
STATE: CA
ZIP: 91203
BUSINESS PHONE: 818-839-5200
MAIL ADDRESS:
STREET 1: 700 NORTH BRAND BLVD.,
STREET 2: SUITE 1400
CITY: GLENDALE
STATE: CA
ZIP: 91203
FORMER COMPANY:
FORMER CONFORMED NAME: SICLONE INDUSTRIES INC
DATE OF NAME CHANGE: 19990413
4
1
doc1.xml
FORM 4
X0306
4
2018-08-24
0
0001083446
Apollo Medical Holdings, Inc.
AMEH
0001438326
Vazquez Adrian
700 N. BRAND BLVD.
SUITE 1400
GLENDALE
CA
91203
0
1
0
0
Co-Chief Medical Officer
Common Stock
2018-08-24
4
M
0
30000
1.5
A
942338
D
Common Stock
2018-08-24
4
M
0
10000
10
A
952338
D
Common Stock
2018-08-24
4
M
0
18574
6.37
A
970912
D
Stock Option (right to buy)
1.5
2018-08-24
4
M
0
30000
0
A
2010-12-09
2020-12-08
Common Stock
30000
33400
D
Stock Option (right to buy)
10
2018-08-24
4
M
0
10000
0
A
2014-07-10
2024-07-10
Common Stock
10000
23400
D
Stock Option (right to buy)
6.37
2018-08-24
4
M
0
18574
0
A
2016-09-14
2021-02-14
Common Stock
18574
4826
D
One third (1/3) of the shares subject to the option vested on December 9, 2010, December 9, 2011 and December 9, 2012, respectively.
One thirty-sixth (1/36) of the shares subject to the option vested on July 10, 2014 and on each monthly anniversary of July 10, 2014, respectively.
The option was approved by the Issuer's Compensation Committee on February 15, 2016, subject to shareholder approval of the plan under which the option was granted. The Issuer's stockholders approved the plan on September 14, 2016. The option vested as to 15,584 shares on February 15, 2016 and the balance of the shares subject to the option vested at a rate of approximately 651 shares per month commencing on March 15, 2016.
The acquisition of the Issuer's common stock reported on this Form 4 resulted from the exercise of options granted by the Issuer's Compensation Committee, a committee solely composed of two or more non-employee directors, and is therefore exempt from section 16(b) of the Securities Exchange Act of 1934, as amended, pursuant to rule 16b-3(d)(1) thereunder.
Adrian Vazquez
2018-08-28